Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Genitourinary 1CNS 1

Conditions

Ovarian Neoplasms 13Fallopian Tube Neoplasms 5Carcinoma, Ovarian Epithelial 5Lung Neoplasms 3Uterine Cervical Neoplasms 2Testicular Neoplasms 2Testicular Germ Cell Tumor 2Seminoma 2Neutropenia 2Endodermal Sinus Tumor 2Central Nervous System Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Breast Neoplasms 2Triple Negative Breast Neoplasms 1Teratoma 1Stomach Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma 1Recurrent Uterine Corpus Sarcoma 1Recurrent Uterine Corpus Carcinoma 1Prostatic Neoplasms 1Lymphoma, Non-Hodgkin 1Head and Neck Neoplasms 1Esophageal Neoplasms 1Endometrial Adenosquamous Carcinoma 1Endometrial Adenocarcinoma 1Dysgerminoma 1Communicable Diseases 1Colorectal Neoplasms 1Carcinoma, Embryonal 1

Interventions

Paclitaxel 2pegfilgrastim 1Taxes 1Sunitinib 1Mental Status and Dementia Tests 1Lapatinib 1Ifosfamide 1Cisplatin 1Albumin-Bound Paclitaxel 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Dysgerminoma × pegfilgrastim × Gynecologic × Clear all
NCT00470366 2017-11-28

Combination Chemotherapy and Pegfilgrastim in Treating Patients With Previously Untreated Germ Cell Tumors

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
60 enrolled 11 charts
CNSGenitourinaryGynecologic

Testicular Germ Cell Tumor, Dysgerminoma, Ovarian Neoplasms, Teratoma, Testicular Neoplasms, Central Nervous System Neoplasms, Carcinoma, Embryonal, Seminoma, Endodermal Sinus Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡